Colgate-Palmolive (CL)
99.67
+1.77 (1.81%)
NYSE · Last Trade: Nov 13th, 4:36 PM EST
News & Press Releases
Celsius vs. Colgate-Palmolive: Which Consumer Goods Stock Is a Better Buy for 2027?fool.com
Celsius's hyper-growth and Pepsi partnership square off against Colgate-Palmolive's steady cash flow and defensive brands, and the answer depends on how much risk you can handle.
Via The Motley Fool · November 13, 2026
These 5 Dividend Aristocrats® Have Raised Payouts for Decadesfool.com
Investors worried about market turmoil may want to look at reliable dividend stocks, and these five stand out.
Via The Motley Fool · November 11, 2026
My Forever Portfolio: 4 Spectacular Stocks You Can Buy Now and Never Sellfool.com
It takes a slightly different mindset when you're investing for a longer time horizon.
Via The Motley Fool · November 11, 2026
Colgate-Palmolive (NYSE:CL) Eyes Breakout With Strong Technical Setupchartmill.com
Via Chartmill · November 11, 2026
Colgate-Palmolive (NYSE:CL) Jumps as Margin Gains and Raised EPS Outlook Offset Revenue Misschartmill.com
Via Chartmill · October 30, 2026
Colgate vs. Chipotle: Which Is the Better Buy for 2027?fool.com
A defensive staple and a fast-casual growth name have both been overshadowed by tech’s run, but one looks poised for a comeback.
Via The Motley Fool · November 9, 2026
Colgate-Palmolive vs. Kraft Heinz: With the Market Turmoil, Which Stock Is a Better Buy?fool.com
Colgate-Palmolive's steady cash flow stands in sharp contrast to Kraft Heinz's costly portfolio overhaul, and the valuation gap between the two may be wider than you expect.
Via The Motley Fool · November 7, 2026
Colgate-Palmolive vs. Hershey: Which Consumer Goods Stock Is the Better Buy for 2027?fool.com
Both of these defensive stocks are growing sales about 6%, but one offers a higher yield and a lower valuation as cocoa costs weigh on its shares.
Via The Motley Fool · November 4, 2026
Here’s Why Dividend Kings Coca-Cola, Procter & Gamble, and Colgate-Palmolive Are Hitting 52-Week Highs Following Midterm Election Resultsfool.com
Investors are piling into dependable dividend stocks following the midterm elections. But after their latest rallies, are these three Dividend Kings still worth buying?
Via The Motley Fool · November 4, 2026
1 Dividend King to Buy Before the New Year and Hold Foreverfool.com
Colgate-Palmolive is a Dividend King that investors shouldn't wait to embrace.
Via The Motley Fool · November 4, 2026
5 Dividend Stocks to Buy in 2027 and Hold for the Next 5 Yearsfool.com
Dividend stocks' total returns have historically beaten dividend non-payers by a wide margin.
Via The Motley Fool · November 4, 2026
3 Dividend Stocks to Buy in November That Keep Payingfool.com
These consumer dividend stocks raised their payouts for 50-plus years through rough stretches and good times.
Via The Motley Fool · November 3, 2026
Colgate-Palmolive vs. Lululemon Athletica: Which Consumer Goods Stock Is a Better Buy in 2026?fool.com
Colgate trades at a steep valuation premium despite slowing growth and margin pressure, while lululemon offers half the Forward P/E with stronger cash generation and a liquid balance sheet.
Via The Motley Fool · November 1, 2026
The top 5 analyst questions from Colgate-Palmolive’s Q3 earnings call
Colgate-Palmolive’s third quarter was marked by broad-based organic sales growth and a positive market reaction, as management attributed the momentum to str...
Via StockStory · November 1, 2026
Colgate-Palmolive: 3 Key Takeaways for Long-Term Investorsfool.com
Cost-cutting programs and pricing discipline are shielding margins from commodity inflation, a structural advantage for long-term compounding.
Via The Motley Fool · October 31, 2026
CL Q3 deep dive: global demand and premium innovation support steady growth amid cost pressures
Consumer products company Colgate-Palmolive (NYSE:CL) reported Q3 2026 results topping the market’s revenue expectations, with sales up 4.6% year on year to ...
Via StockStory · October 31, 2026
Colgate-Palmolive Q3 Earnings Call Highlightsmarketbeat.com
Colgate-Palmolive (NYSE:CL) said it delivered broad-based organic sales growth and higher earnings in the third quarter of 2026, supported by emerging-market momentum, premium innovation, productivity programs and strong performance at its Hill’s pet nutrition business.
Chairman, President and Chie
Via MarketBeat · October 30, 2026
Colgate (CL) Q3 2026 Earnings Call Transcriptfool.com
Pricing and productivity offset commodity inflation as organic sales grew 3.6%.
Via The Motley Fool · October 30, 2026
Colgate-Palmolive (NYSE:CL) posts better-than-expected sales in Q3 2026, stock soars
Consumer products company Colgate-Palmolive (NYSE:CL) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 4.6% year on year...
Via StockStory · October 30, 2026
S&P 500 Premarket Gainers and Losers on Oct. 30, 2026chartmill.com
Via Chartmill · October 30, 2026
Colgate-Palmolive Announces 3rd Quarter 2026 Results
Colgate-Palmolive Company (NYSE:CL):
By Colgate-Palmolive Company · Via Business Wire · October 30, 2026
How to stay on top of your oral health while on your GLP-1 journey
(BPT) - Did you know that if you are on a GLP-1, you may be more prone to certain oral health problems, like cavities? Some people taking GLP-1s have experienced side effects including dry mouth, halitosis (bad breath), and decreased saliva, which may increase your risk for cavities and/or gingivitis. That means it's especially important to maintain good oral health practices while on this type of medication.
Via Brandpoint · October 29, 2026
Colgate-Palmolive (CL) reports Q3: everything you need to know ahead of earnings
Consumer products company Colgate-Palmolive (NYSE:CL) will be reporting results this Friday morning. Here’s what investors should know. Colgate-Palmolive met...
Via StockStory · October 28, 2026
Celsius vs. Colgate-Palmolive: Which Stock Should Investors Consider Before the Start of 2027?fool.com
One is a growth stock but faces Pepsi dependency; the other is a more mature company but has massive operating cash flow.
Via The Motley Fool · October 23, 2026